ReviewInternational journal of molecular sciences2024

Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems-A Literature Review.

Viviana Elian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.